These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35038609)

  • 1. Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients.
    Crystal S; Nowels M; Samples H; Olfson M; Williams AR; Treitler P
    Drug Alcohol Depend; 2022 Mar; 232():109269. PubMed ID: 35038609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of medications for opioid use disorder with reduced risk of repeat opioid overdose in Medicaid: A cohort study.
    Tipping AD; Nowels M; Moore C; Samples H; Crystal S; Olfson M; Williams AR; Heaps-Woodruff J
    J Subst Use Addict Treat; 2024 Feb; 157():209218. PubMed ID: 37984564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study.
    Burns M; Tang L; Chang CH; Kim JY; Ahrens K; Allen L; Cunningham P; Gordon AJ; Jarlenski MP; Lanier P; Mauk R; McDuffie MJ; Mohamoud S; Talbert J; Zivin K; Donohue J
    Addiction; 2022 Dec; 117(12):3079-3088. PubMed ID: 35652681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.
    Hartung DM; Markwardt S; Johnston K; Geddes J; Baker R; Leichtling G; Hildebran C; Chan B; Cook RR; McCarty D; Ghitza U; Korthuis PT
    Addict Sci Clin Pract; 2022 Aug; 17(1):45. PubMed ID: 35986384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of clinic switching and continuity of medication for opioid use disorder in a Medicaid-enrolled population.
    Cole ES; Drake C; DiDomenico E; Sharbaugh M; Kim JY; Nagy D; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kmiec J; Kelley D; Donohue JM
    Drug Alcohol Depend; 2021 Apr; 221():108633. PubMed ID: 33631544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose.
    Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Intern Med; 2024 Aug; 184(8):954-962. PubMed ID: 38884975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medically treated opioid overdoses among New Jersey Medicaid beneficiaries: Rapid growth and complex comorbidity amid growing fentanyl penetration.
    Crystal S; Nowels M; Olfson M; Samples H; Williams AR; Treitler P
    J Subst Abuse Treat; 2021 Dec; 131():108546. PubMed ID: 34391586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2023 May; 80(5):508-514. PubMed ID: 36988913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations Between Inpatient Induction on Medications for Opioid Use Disorder and Postdischarge Medications for Opioid Use Disorder Adherence, Overdose, and Service Use.
    Noam KR; Schmutte TJ; Pirard S; Bourdon C; Langless D; Plant R
    J Addict Med; 2023 May-Jun 01; 17(3):e199-e201. PubMed ID: 37267183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study.
    Smolina K; Crabtree A; Chong M; Park M; Mill C; Zhao B; Schütz CG
    Subst Abus; 2022; 43(1):92-98. PubMed ID: 32441588
    [No Abstract]   [Full Text] [Related]  

  • 12. Emergency Department Peer Support Program and Patient Outcomes After Opioid Overdose.
    Treitler P; Crystal S; Cantor J; Chakravarty S; Kline A; Morton C; Powell KG; Borys S; Cooperman NA
    JAMA Netw Open; 2024 Mar; 7(3):e243614. PubMed ID: 38526490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
    Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
    JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose.
    Klemperer EM; Wreschnig L; Crocker A; King-Mohr J; Ramniceanu A; Brooklyn JR; Peck KR; Rawson RA; Evans EA
    J Subst Use Addict Treat; 2023 Sep; 152():209103. PubMed ID: 37311520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for opioid use disorder in the Florida medicaid population: Using a cascade of care model to evaluate quality.
    Johnson K; Hills H; Ma J; Brown CH; McGovern M
    Am J Drug Alcohol Abuse; 2021 Mar; 47(2):220-228. PubMed ID: 33054435
    [No Abstract]   [Full Text] [Related]  

  • 16. Receipt of Addiction Treatment After Opioid Overdose Among Medicaid-Enrolled Adolescents and Young Adults.
    Alinsky RH; Zima BT; Rodean J; Matson PA; Larochelle MR; Adger H; Bagley SM; Hadland SE
    JAMA Pediatr; 2020 Mar; 174(3):e195183. PubMed ID: 31905233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an emergency department-based opioid overdose survivor intervention: Difference-in-difference analysis of electronic health record data to assess key outcomes.
    Watson DP; Weathers T; McGuire A; Cohen A; Huynh P; Bowes C; O'Donnell D; Brucker K; Gupta S
    Drug Alcohol Depend; 2021 Apr; 221():108595. PubMed ID: 33610095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription Opioid Dispensing Patterns Prior to Heroin Overdose in a State Medicaid Program: a Case-Control Study.
    Hartung DM; Johnston KA; Hallvik S; Leichtling G; Geddes J; Hildebran C; Keast S; Chan B; Korthuis PT
    J Gen Intern Med; 2020 Nov; 35(11):3188-3196. PubMed ID: 32935311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses?
    Medicaid Outcomes Distributed Research Network
    J Subst Abuse Treat; 2022 Nov; 142():108807. PubMed ID: 35649885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public Health Interventions and Overdose-Related Outcomes Among Persons With Opioid Use Disorder.
    Nataraj N; Rikard SM; Zhang K; Jiang X; Guy GP; Rice K; Mattson CL; Gladden RM; Mustaquim DM; Illg ZN; Seth P; Noonan RK; Losby JL
    JAMA Netw Open; 2024 Apr; 7(4):e244617. PubMed ID: 38568691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.